Literaturverzeichnis
zum Titelthema „Prävention in der klinischen Toxikologie; Was ist gesichert – was ist Mythos?“
Bayerisches Ärzteblatt 12/2013, Seite 632 ff.
von Verena Schrettl und Universitätsprofessor Dr. Florian Eyer
[1] N. Felgenhauer and T. Zilker, “[Emergencies in general practice. Acute poisoning with medicinal drugs],” MMW Fortschr. Med., vol. 144, no. 19, pp. 42–45, May 2002.
[2] United Nations Environment Programme, International Labour Organisation, World Health Organization, Inter-Organization Programme for the Sound Management of Chemicals, and International Program on Chemical Safety, Guidelines on the prevention of toxic exposures education and public awareness activities. Geneva:
International Labour Organization, United Nations Environmental Programme, World Health Organization, 2004.
[3] K. E. von Mühlendahl, Vergiftungen im Kindesalter: 40 Tabellen. Stuttgart [u.a.]:
Thieme, 2003.
[4] B. S. Fertel, L. S. Nelson, and D. S. Goldfarb, “Extracorporeal Removal Techniques for the Poisoned Patient: A Review for the Intensivist,” J. Intensive Care Med., vol. 25, no.
3, pp. 139–148, May 2010.
[5] J. Höjer, W. G. Troutman, K. Hoppu, A. Erdman, B. E. Benson, B. Mégarbane, R.
Thanacoody, R. Bedry, and E. M. Caravati, “Position paper update: ipecac syrup for gastrointestinal decontamination,” Clin. Toxicol., vol. 51, no. 3, pp. 134–139, Mar. 2013.
[6] B. E. Benson, K. Hoppu, W. G. Troutman, R. Bedry, A. Erdman, J. Höjer, B.
Mégarbane, R. Thanacoody, and E. M. Caravati, “Position paper update: gastric lavage for gastrointestinal decontamination,” Clin. Toxicol., vol. 51, no. 3, pp. 140–146, Mar.
2013.
[7] P. A. Chyka, D. Seger, E. P. Krenzelok, J. A. Vale, American Academy of Clinical Toxicology, and European Association of Poisons Centres and Clinical Toxicologists,
“Position paper: Single-dose activated charcoal,” Clin. Toxicol. Phila. Pa, vol. 43, no. 2, pp. 61–87, 2005.
[8] F.-X. Reichl, Taschenatlas Toxikologie. Stuttgart: Thieme, 2009.
[9] T. R. Zilker, Klinische Toxikologie für die Notfall- und Intensivmedizin. Bremen; London;
Boston, Mass: UNI-MED-Verl., 2008.
[10] P. A. Chyka, “Multiple-dose activated charcoal and enhancement of systemic drug clearance: summary of studies in animals and human volunteers,” J. Toxicol. Clin.
Toxicol., vol. 33, no. 5, pp. 399–405, 1995.
[11] A. S. Shalkham, B. M. Kirrane, R. S. Hoffman, D. S. Goldfarb, and L. S. Nelson, “The Availability and Use of Charcoal Hemoperfusion in the Treatment of Poisoned Patients,”
Am. J. Kidney Dis., vol. 48, no. 2, pp. 239–241, Aug. 2006.
[12] F. Eyer and T. Zilker, “Expositionen mit Ätzstoffen,” Ther. Umsch., vol. 66, no. 5, pp.
379–386, May 2009.
